医院就诊人群与普查人群中大肠癌患者临床资料的比较

来源 :胃肠病学 | 被引量 : 0次 | 上传用户:flyingmain
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
背景:在我国有无必要开展大肠癌普查仍存在一定争议。目的:比较、分析医院就诊人群与普查人群中大肠癌患者临床资料的异同,探讨普查在大肠癌早期诊断中的作用。方法:就诊组:由协作组各成员医院按统一设计的调查表,前瞻性地登记2002年4月1日~2003年3月31日到医院就诊,并接受结肠镜检查的大肠癌患者的全部临床资料。普查组:采用“序贯粪便隐血筛检技术”,于2001年3~6月对北京地区约2万名35岁以上的自然人群进行大肠癌普查。两组大肠癌患者的诊断均经术后病理检查证实。结果:就诊组和普查组患者中,≥50岁者分别占81.9%和83.3%。就诊组DukesA、B期患者占41.1%,普查组占91.7%(P<0.001)。普查人群中存在大肠癌高危因素者的大肠癌检出率为0.28%,无高危因素者的检出率为0.05%(P<0.001)。就诊组中,内镜表现为隆起型病变者44.7%是DukesA、B期患者,溃疡型病变者仅10.0%是DukesA、B期患者(P<0.001);DukesA、B期患者的粪便隐血试验阳性率为78.5%,C、D期患者为81.9%(P>0.05),提示粪便隐血试验阳性率与大肠癌分期无关;DukesC、D期患者的血清CEA阳性率显著高于A、B期患者(P=0.019);高、中分化癌中DukesA、B期患者占51.8%,低分化癌中DukesA、B期患者仅占26.5%(P<0.001)。结论:近年北京地区的大肠癌发病率较以前明显上升 Background: There is still some controversy about the necessity of carrying out the general survey of colorectal cancer in our country. OBJECTIVE: To compare and analyze the similarities and differences of clinical data of patients with colorectal cancer in hospitals and censuses, and to explore the role of censuses in the early diagnosis of colorectal cancer. Methods: The visiting group: all the collaborating group of members of the hospital according to a unified design of the questionnaire, prospective registration April 1, 2002 ~ March 31, 2003 to the hospital and colonoscopy in patients with colorectal cancer all clinical information. Census group: “Sequential fecal occult blood screening technology”, from March to June 2001 in Beijing about 20,000 people over the age of 35 for colorectal cancer screening. Two groups of patients with colorectal cancer were confirmed by pathological examination. Results: In the treatment group and the census group, those over 50 years old accounted for 81.9% and 83.3% respectively. The treatment group DukesA, B patients accounted for 41.1%, the survey group accounted for 91.7% (P <0.001). The prevalence of colorectal cancer was 0.28% in those with high risk of colorectal cancer in the census population, and 0.05% (P <0.001) in those without high risk factors. In the treatment group, 44.7% of patients with Dukes A and B lesions showed endoscopic Dukes A and B disease, and only 10.0% of Dukes A and B patients with Dukes A and B disease (P <0.001). Dukes A and B patients had positive fecal occult blood test (P> 0.05). The positive rate of fecal occult blood test was not related to the staging of colorectal cancer. The positive rate of CEA in DukesC and D patients was significantly higher than that in patients with A and B P = 0.019). DukesA and B patients accounted for 51.8% in high and moderately differentiated cancers and only 26.5% in patients with poorly differentiated cancers DukesA and B (P <0.001). Conclusion: In recent years, the incidence of colorectal cancer in Beijing increased significantly than before
其他文献
目的:进一步探讨阑尾类癌的临床、病理及免疫组化特点。方法:复习13例阑尾类癌的临床、病理资料及HE切片,13例均行嗜铬颗粒蛋白A(CgA)、神经元特异性烯醇化酶(NSE)免疫组化标
目的探讨复杂胫骨平台骨折的手术治疗方法.方法手术治疗复杂胫骨平台骨折 48例,骨折类型按 Schatzker分型,其中Ⅲ型 12例,Ⅳ型 9例,Ⅴ型 14例,Ⅵ型 13例,均经切开复位、钢板
本文通过回顾医学教育发展的历史,考察美国医学院校的做法与经验,得出临床医学与基础医学的结合是医学教育发展的必然以及医学教育离不开医院的结论.同时,介绍了复旦大学上海
血液高凝、血管内皮损伤和血流缓慢是静脉血栓(venous thrombosis,VT)形成的三大危险因素.其中由于许多遗传性因素和获得性因素,使体内抗凝因子和凝血因子功能失衡,造成血液
目的通过分析337例乳腺病变的钼靶X线征象,总结出各种病变的特征性表现,以提高乳腺疾病的钼靶X线诊断水平.方法337例均进行钼靶照片.乳腺导管内乳头状瘤患者除照乳腺平片外,
目的 :探讨增殖细胞核抗原 (PCNA)在原发性肝细胞癌 (HCC)中的表达及意义。方法 :4 3例肝细胞癌患者在B型超声引导下行肝穿刺活检获取肝癌组织标本 ,并应用免疫组织化学方法
[目的]探讨ER、c-erbB2、p21、PCNA在乳腺癌的表达及其临床意义.[方法]应用免疫组化SP法,检测300例乳腺癌ER、c-erbB2、p21、PCNA表达.[结果]ER、c-erbB2、p21、PCNA在乳腺癌
目的旨在研究经皮冠状动脉(冠脉)内β-射线放射疗法(β-放疗, Novoste)与切割球囊成形术(CBA)联合治疗支架内再狭窄(ISR)的疗效及其安全性.方法冠脉内支架置入术后ISR>70%的
目的:探讨肾囊肿内肾癌的诊断治疗。方法:对107例肾囊肿患者6例囊肿囊壁肾癌患者的资料进行分析。结果:6例患者中术前诊断囊性肾癌者4例,术中发现1例,术后病理回报1例。结论:
目的:观察NP方案治疗NSCLC的临床疗效,探讨治疗晚期NSCLC有效的化疗方案。方法:入选103例晚期NSCLC患者,随机分为观察组(NP方案)50例及对照组(CAP方案)53例,均完成3个周期化